AACR meeting
This article was originally published in The Tan Sheet
Executive Summary
American Association for Cancer Research's annual meeting will take place July 11-14 at the Washington Convention Center in Washington, D.C., according to notice posted on group's 1Web site April 23. Initially scheduled to occur April 5-9 in Toronto, the meeting was postponed due to concerns about SARS. Research slated for presentation at the meeting includes a report on weekly NSAID use and its effect on reducing breast cancer incidence, study finding black cohosh may increase chemotherapy drugs' effectiveness (2"The Tan Sheet" April 21, 2003, p. 16)...
You may also be interested in...
American Association For Cancer Research In Brief
The AACR annual meeting, scheduled to be held in Toronto April 5-9, was cancelled due to concerns about the SARS outbreak. However, research abstracts were still submitted to the association.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.